These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 8328794

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin.
    Powell M, Seetulsingh P, Williams JD.
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():175-81. PubMed ID: 2808206
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Carbapenems as inhibitors of OXA-13, a novel, integron-encoded beta-lactamase in Pseudomonas aeruginosa.
    Mugnier P, Podglajen I, Goldstein FW, Collatz E.
    Microbiology (Reading); 1998 Apr; 144 ( Pt 4)():1021-1031. PubMed ID: 9579076
    [Abstract] [Full Text] [Related]

  • 31. Role of OmpD2 and chromosomal beta-lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa.
    Satake S, Yoneyama H, Nakae T.
    J Antimicrob Chemother; 1991 Aug; 28(2):199-207. PubMed ID: 1778851
    [Abstract] [Full Text] [Related]

  • 32. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
    Mushtaq S, Vickers A, Woodford N, Livermore DM.
    J Antimicrob Chemother; 2017 Jun 01; 72(6):1688-1695. PubMed ID: 28333319
    [Abstract] [Full Text] [Related]

  • 33. Mechanisms of beta-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey.
    Bonfiglio G, Laksai Y, Franchino L, Amicosante G, Nicoletti G.
    J Antimicrob Chemother; 1998 Dec 01; 42(6):697-702. PubMed ID: 10052891
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
    Martínez-Beltrán J, Calderón C, Sierra MP, Alvarez M, Cantón R.
    Enferm Infecc Microbiol Clin; 1997 Sep 01; 15 Suppl 1():20-6. PubMed ID: 9410065
    [Abstract] [Full Text] [Related]

  • 38. [Antimicrobial activity of carbapenems and the combined effect with aminoglycoside against recent clinical isolates of Pseudomonas aeruginosa].
    Tasaka K, Ishida A, Chinzei T.
    Jpn J Antibiot; 2002 Apr 01; 55(2):181-6. PubMed ID: 12071095
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.